REQUEST A DEMO
Total
USD $0.00
Search more companies

Omega Pharma Baltics SIA (Latvia)

Main Activities: Research and Development in the Social Sciences and Humanities | Marketing Research and Public Opinion Polling
Full name: Omega Pharma Baltics SIA Profile Updated: December 24, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Omega Pharma Baltics SIA is a company in Latvia, with a head office in Marupe. It operates in the Research and Development in the Social Sciences and Humanities industry. It was incorporated on April 16, 1999. 16 (2023) employees currently work for Omega Pharma Baltics SIA. The latest financial highlights indicate a net sales revenue increase of 21.55% in 2024. A growth of 28.83% was recorded in its total assets.

Headquarters
Maldugunu iela 2
Marupe; Marupes municipality; Postal Code: 2167

Contact Details: Purchase the Omega Pharma Baltics SIA report to view the information.

Basic Information
Total Employees:
Purchase the Omega Pharma Baltics SIA report to view the information.
Registered Capital:
Purchase the Omega Pharma Baltics SIA report to view the information.
Financial Auditors:
Purchase the Omega Pharma Baltics SIA report to view the information.
Incorporation Date:
April 16, 1999
Key Executives
Purchase this report to view the information.
Member of Management Board
Purchase this report to view the information.
Member of Management Board
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Omega Pharma Baltics SIA report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
21.55%
Total operating revenue
21.55%
Operating profit (EBIT)
20.82%
EBITDA
20.82%
Net Profit (Loss) for the Period
21.55%
Total Assets
28.83%
Total Equity
29.52%
Operating Profit Margin (ROS)
-0.04%
Net Profit Margin
0%
Return on Equity (ROE)
-1.5%
Quick Ratio
0.05%
Cash Ratio
-0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?